We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+2.89%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.19B
AUM Growth
+$235M
Cap. Flow
+$236M
Cap. Flow %
19.86%
Top 10 Hldgs %
39.34%
Holding
173
New
49
Increased
30
Reduced
31
Closed
21

Top Buys

Rank Stock Value
1
PCG icon
PG&E
PCG
+$42M
2
NYRT
New York REIT, Inc.
NYRT
+$25.7M
3
TRUE
TrueCar
TRUE
+$21.9M
4
TRVG
trivago
TRVG
+$19M
5
TWX
Time Warner Inc
TWX
+$18.9M

Top Sells

Rank Stock Value
1
AABA
Altaba Inc
AABA
+$21.5M
2
GS icon
Goldman Sachs
GS
+$16.6M
3
AGN
Allergan plc
AGN
+$12.7M
4
COF icon
Capital One
COF
+$11.7M
5
CARS icon
Cars.com
CARS
+$8.47M

Sector Composition

Rank Sector Weight
1 Healthcare 10.68%
2 Consumer Discretionary 8.19%
3 Communication Services 6.39%
4 Financials 4.86%
5 Real Estate 4.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EIX icon
51
Edison International
EIX
$30.3B
$6.32M 0.53%
+100,000
New +$7.63M
ALDX icon
52
Aldeyra Therapeutics
ALDX
$95.3M
$6.22M 0.52%
915,000
+79,486
+10% +$524K
LRMR icon
53
Larimar Therapeutics
LRMR
$398M
$6.01M 0.51%
108,333
– –
PEP icon
54
PUT
PepsiCo
PEP
$191B
$6M 0.51%
50,000
-50,000
-50% -$5.71M
SQBG
55
DELISTED
Sequential Brands Group, Inc.
SQBG
$5.96M 0.5%
83,785
+6,831
+9% +$578K
GLMD icon
56
Galmed Pharmaceuticals
GLMD
$4.05M
$5.94M 0.5%
3,607
+555
+18% +$820K
ARRY
57
DELISTED
Array Biopharma Inc
ARRY
$5.76M 0.49%
450,000
-50,000
-10% -$569K
HYAC
58
DELISTED
Haymaker Acquisition Corp. Class A Common Stock
HYAC
$5.74M 0.48%
+600,000
New +$5.73M
BX icon
59
Blackstone
BX
$106B
$5.44M 0.46%
170,000
-30,000
-15% -$977K
NIHD
60
DELISTED
NII Holdings, Inc. Common Stock
NIHD
$5.38M 0.45%
12,671,154
+6,575,726
+108% +$2.49M
FATE icon
61
Fate Therapeutics
FATE
$283M
$5.22M 0.44%
853,800
+175,000
+26% +$781K
RDHL
62
Redhill Biopharma
RDHL
$4.26M
$5.14M 0.43%
+999
New +$6.73M
TCON
63
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$4.99M 0.42%
7,450
+2,475
+50% +$1.49M
DRNA
64
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$4.97M 0.42%
550,000
-210,233
-28% -$1.55M
ECHO
65
EchoStar
ECHO
$25.1B
$4.79M 0.4%
98,720
-61,609
-38% -$2.86M
WU icon
66
PUT
Western Union
WU
$2.55B
$4.75M 0.4%
250,000
+150,000
+150% +$2.94M
CVON
67
DELISTED
ConvergeOne Holdings, Inc. Class A Common Stock
CVON
$4.49M 0.38%
+450,000
New +$4.41M
MRNS
68
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$4.49M 0.38%
+137,500
New +$3.71M
TWNKW
69
DELISTED
Hostess Brands, Inc. Warrants
TWNKW
$3.91M 0.33%
1,679,000
– –
ORCL icon
70
PUT
Oracle
ORCL
$345B
$3.55M 0.3%
75,000
– –
SRRA
71
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$3.44M 0.29%
+23,044
New +$2.21M
WSCWW
72
DELISTED
WillScot Corporation Warrant
WSCWW
$3.18M 0.27%
+2,207,000
New +$2.73M
SMPLW
73
DELISTED
The Simply Good Foods Company Warrant
SMPLW
$3.11M 0.26%
+800,000
New +$2.18M
AGRO icon
74
Adecoagro
AGRO
$1.48B
$3.1M 0.26%
300,000
– –
OTIC
75
DELISTED
Otonomy, Inc.
OTIC
$3.05M 0.26%
+550,000
New +$2.39M
1 2
3
4 5

Similar funds

QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return

683 Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, 683 Capital Management held 173 positions worth $1.19B, up 25% from $952M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

683 Capital Management deployed $236M of net new capital in Q4 2017, opening 49 new positions and adding to 30 existing holdings. Its largest new stake was PG&E: 750,000 shares worth $33.6M.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Cars.com, an estimated $8.47M trimmed.

  • 683 Capital Management's largest Q4 2017 buy was PG&E: 750,000 shares worth $33.6M.
  • 683 Capital Management added most to New York REIT, Inc. in Q4 2017, an estimated $25.7M increase.
  • 683 Capital Management's biggest Q4 2017 reduction was Cars.com, cutting an estimated $8.47M.
  • 683 Capital Management fully exited Altaba Inc in Q4 2017, selling an estimated $21.5M.
  • 683 Capital Management's ten largest holdings make up 39% of its $1.19B portfolio in Q4 2017.
  • 683 Capital Management opened 49 new positions and closed 21 in Q4 2017.
  • 683 Capital Management's portfolio value rose 25% quarter-over-quarter to $1.19B.

Based on 683 Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.